Retrospective, Multinational, Drug Utilisation Study (DUS) to Investigate the Routine Use of Hydroxyethyl Starch (HES)-containing Infusion Solutions in HES-Accredited European (EU) Hospitals after Implementation of a Set of Risk Minimisation Measures (HE06-027-CNI)

20/11/2019
22/02/2024
EU PAS number:
EUPAS32145
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

EU-HES-DUS-HE06-027-CNI-CSP-Final_v2.0

English (533.31 KB - PDF) View document
Updated protocol

EU-HES-DUS-HE06-027-CNI-CSP-v4.0-Abstract-for-ENCePP

First published: 22/02/2024
English (179.79 KB - PDF) View document
Study results
Study results

HE06-027-CNI-CSR-v2.0-Abstract-for-ENCePP

English (129.25 KB - PDF) View document
Study report
Other information